World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
16263
World Ranking
2431
National Ranking
1163

David M. Lewinsohn publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David M. Lewinsohn sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 195 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David M. Lewinsohn D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David M. Lewinsohn sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David M. Lewinsohn is affiliated with Oregon Health & Science University in the United States. Their research primarily focuses on immunology and microbiology, with a strong emphasis on infectious diseases and pulmonary medicine. Their scientific work encompasses a range of topics related to immune cell functions and interactions, particularly involving T-cell and B-cell immunology.

Their main fields of study include:

  • Immunology and Microbiology
  • Medicine

Within these fields, the subfields of research extend to:

  • Immunology
  • Epidemiology
  • Infectious Diseases
  • Molecular Biology
  • Pulmonary and Respiratory Medicine

The central topics of their work focus on areas such as:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Tuberculosis Research and Epidemiology
  • Immunotherapy and Immune Responses
  • Mycobacterium research and diagnosis
  • Cytomegalovirus and herpesvirus research
  • Immunodeficiency and Autoimmune Disorders

Recent papers by David M. Lewinsohn highlight their ongoing contributions to the body of knowledge in immunology and infectious disease research. Some notable publications include:

  • "The status of tuberculosis vaccine development," 2020, The Lancet Infectious Diseases
  • "Ligand-dependent downregulation of MR1 cell surface expression," 2020, Proceedings of the National Academy of Sciences
  • "Human lung-resident mucosal-associated invariant T cells are abundant, express antimicrobial proteins, and are cytokine responsive," 2022, Communications Biology
  • "Effects of BCG vaccination on donor unrestricted T cells in two prospective cohort studies," 2022, EBioMedicine
  • "Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence," 2022, mBio

Their frequent co-authors include:

  • Gwendolyn Swarbrick
  • Deborah A. Lewinsohn
  • Aneta Worley
  • Meghan Cansler
  • Corinna A. Kulicke

David M. Lewinsohn's work has been published extensively in several scientific venues. They have multiple publications in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Scientific Reports
  • The Journal of Immunology
  • Communications Biology

Best Publications

  • Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children

    David M. Lewinsohn;Michael K. Leonard;Philip A. LoBue;David L. Cohn

  • Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells

    Marielle C. Gold;Marielle C. Gold;Stefania Cerri;Susan Smyk-Pearson;Meghan E. Cansler

  • Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis

    Kristi M. Guinn;Mark J. Hickey;Sanjeev K. Mathur;Kelly L. Zakel

  • Vitamin D Is Required for IFN-γ–Mediated Antimicrobial Activity of Human Macrophages

    Mario Fabri;Steffen Stenger;Dong Min Shin;Jae Min Yuk

  • Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.

    Paul K. Drain;Kristina L. Bajema;David Dowdy;Keertan Dheda

  • Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes.

    D M Lewinsohn;R F Bargatze;E C Butcher

  • Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization.

    Hannah Priyadarshini Gideon;Jia Yao Phuah;Amy J. Myers;Bryan D. Bryson

  • Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells

    Roman Tomazin;Jessica Boname;Jessica Boname;Nagendra R. Hegde;David M. Lewinsohn

  • HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells.

    Amy S. Heinzel;Jeff E. Grotzke;Jeff E. Grotzke;Rebecca A. Lines;Deborah A. Lewinsohn

  • Frequencies of HCV‐specific effector CD4+ T cells by flow cytometry: Correlation with clinical disease stages

    Hugo R. Rosen;Camette Miner;Anna W. Sasaki;David M. Lewinsohn

  • Immune evasion versus recovery after acute hepatitis C virus infection from a shared source

    Ian Tester;Susan Smyk-Pearson;Susan Smyk-Pearson;Ping Wang;Anne Wertheimer

  • CHARACTERIZATION OF HUMAN CD8+ T CELLS REACTIVE WITH MYCOBACTERIUM TUBERCULOSIS-INFECTED ANTIGEN-PRESENTING CELLS

    David M. Lewinsohn;David M. Lewinsohn;Mark R. Alderson;Andria L. Briden;Stanley R. Riddell

  • MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage

    Marielle C. Gold;James E. McLaren;Joseph A. Reistetter;Sue Smyk-Pearson

  • Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family

    Davin C. Dillon;Mark R. Alderson;Craig H. Day;David M. Lewinsohn

  • Mycobacterium tuberculosis-specific CD8+ T Cells Preferentially Recognize Heavily Infected Cells

    Deborah A. Lewinsohn;Amy S. Heinzel;James M. Gardner;Liqing Zhu

  • Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination

    Deborah A. Lewinsohn;David M. Lewinsohn;Thomas J. Scriba

  • Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B

    Deborah A Lewinsohn;Ervina Winata;Ervina Winata;Gwendolyn M Swarbrick;Gwendolyn M Swarbrick;Katie E Tanner;Katie E Tanner

  • Identification of a Human HLA-E-Restricted CD8+ T Cell Subset in Volunteers Immunized with Salmonella enterica Serovar Typhi Strain Ty21a Typhoid Vaccine

    Rosângela Salerno-Gonçalves;Marcelo Fernandez-Viña;David M. Lewinsohn;Marcelo B. Sztein

  • Expression Cloning of an Immunodominant Family of Mycobacterium tuberculosis Antigens Using Human Cd4+ T Cells

    Mark R. Alderson;Teresa Bement;Craig H. Day;Liqing Zhu

  • Role of CD8+ T lymphocytes in control of Mycobacterium tuberculosis infection

    Jeff E. Grotzke;David M. Lewinsohn

  • Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress

    Marielle C. Gold;Tarek Eid;Sue Smyk-Pearson;Yvonne Eberling

Frequent Co-Authors

Mark R. Alderson
Mark R. Alderson Program for Appropriate Technology in Health
Eugene C. Butcher
Eugene C. Butcher Stanford University
Hugo R. Rosen
Hugo R. Rosen University of Southern California
William H. Hildebrand
William H. Hildebrand University of Oklahoma Health Sciences Center
Thomas J. Scriba
Thomas J. Scriba University of Cape Town
Jamie Rossjohn
Jamie Rossjohn Monash University
Willem A. Hanekom
Willem A. Hanekom University College London
David R. Sherman
David R. Sherman University of Washington
W. Henry Boom
W. Henry Boom Case Western Reserve University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers alongside studying Immunology in the USA, exploring various nursing credentials can be highly beneficial. Programs like the cheapest pmhnp certificate programs offer affordable paths to specialize in psychiatric-mental health, aligning well with immunology’s focus on the body’s defense systems.

Understanding the earning potential is equally important. Resources detailing dnp salary transparency provide clear insights into Doctor of Nursing Practice salaries across different states, helping students make informed decisions about their investment in education.

For nurses aiming to enhance their expertise, pursuing an acute care nurse practitioner certification is a strategic move. This specialization prepares professionals for high-demand clinical environments where immunological knowledge is vital.

Additionally, accelerated programs such as those highlighted in the accelerated fnp programs section offer fast-tracked options for becoming a Family Nurse Practitioner, integrating comprehensive health sciences relevant to immunological studies and patient care.

Best Scientists Citing David M. Lewinsohn

Trending Scientists

Recently Published Articles